1. Home
  2. POWL vs PRAX Comparison

POWL vs PRAX Comparison

Compare POWL & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Industries Inc.

POWL

Powell Industries Inc.

N/A

Current Price

$193.30

Market Cap

7.2B

Sector

Energy

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$260.97

Market Cap

8.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POWL
PRAX
Founded
1947
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.3B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
POWL
PRAX
Price
$193.30
$260.97
Analyst Decision
Buy
Strong Buy
Analyst Count
4
19
Target Price
$280.00
★ $644.42
AVG Volume (30 Days)
★ 470.9K
441.7K
Earning Date
11-17-2026
11-04-2026
Dividend Yield
★ 0.19%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.81
N/A
Revenue
★ $448,716,000.00
N/A
Revenue This Year
$7.85
N/A
Revenue Next Year
$24.54
$39,458.00
P/E Ratio
$49.68
★ N/A
Revenue Growth
★ 13.34
N/A
52 Week Low
$167.31
$50.56
52 Week High
$612.50
$392.70

Technical Indicators

Market Signals
Indicator
POWL
PRAX
Relative Strength Index (RSI) 51.62 27.51
Support Level $180.98 $238.77
Resistance Level $219.27 $337.47
Average True Range (ATR) 7.44 13.90
MACD 1.43 -1.34
Stochastic Oscillator 48.22 2.21

Price Performance

Historical Comparison
POWL
PRAX

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: